Literature DB >> 28400374

Aqueous outflow facility after phacoemulsification with or without goniosynechialysis in primary angle closure: a randomised controlled study.

Ian A Rodrigues1, Pouya Alaghband1, Laura Beltran Agullo1, Elizabeth Galvis1, Stephanie Jones1, Rahat Husain1, K Sheng Lim1.   

Abstract

BACKGROUND: Goniosynechialysis (GSL) to remove peripheral anterior synechiae (PAS) alongside standard cataract surgery has potential theoretical advantages, Published randomised trials, however, have not shown conclusive functional benefits and aqueous outflow changes following GSL are unknown. This study aimed to compare electronic Shiøtz tonographic aqueous outflow facility (TOF) following phacoemulsification with or without GSL in patients with primary angle closure (PAC) and PAC glaucoma. Secondary outcomes were changes in intraocular pressure (IOP) and use of glaucoma medications.
METHODS: Prospective randomised pilot study of 26 patients on glaucoma medication, with ≥90° PAS and significant lens opacity. Patients were randomised 1:1 to receive phacoemulsification with intraocular lens (IOL) implantation only (phaco) or phacoemulsification with IOL plus GSL (phaco-GSL).
RESULTS: Fourteen patients were randomised to phaco-GSL and 12 to phaco alone. TOF increased with phaco-GSL from 0.099±0.07 μL/min/mm Hg to 0.194±0.07, μL/min/mm Hg, p=0.0006, while the phaco group showed no significant change. IOP reduced in both groups, but reduced significantly more following phaco-GSL (46.0%) compared with phaco alone (27.6%, p=0.04). Medication use and extent of PAS only reduced with phaco-GSL, from 0.923±0.86 to 0.384±0.18 medications, p=0.0279, and from 249.2±83.4 to 110.8±53.9° PAS, 6 months postoperatively. No serious adverse events occurred in either group.
CONCLUSIONS: Eyes randomised to both surgical groups had similar and good outcomes at 6 months in this pilot study. However, only eyes undergoing GSL combined with standard phacoemulsification had significantly increased TOF, reduced glaucoma medication dependence and PAS postoperatively. GSL should therefore be considered in such patients. TRIAL REGISTRATION NUMBER: NCT00719290, Results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Angle; Aqueous humour; Glaucoma; Lens and zonules; Treatment Surgery

Mesh:

Year:  2016        PMID: 28400374     DOI: 10.1136/bjophthalmol-2016-309556

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Outcomes of chronic angle-closure glaucoma treated by phacoemulsification and endocyclophotocoagulation with or without endoscopically goniosynechialysis.

Authors:  Xing Wu; Ying Wang; Xi Liu; Zhao-Hui Li; Li-Qin Deng; Dai-Shi Chen; Da-Jiang Wang
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

2.  Outcomes of effective goniosynechialysis under an endoscopic view combined with phacoemulsification in residual angle-closure glaucoma with lens opacity: 6-month results.

Authors:  Wei Tang; Zhengwei Zhang; Yujie Zhang; Xiaolei Yin; Yinong Zhang; Qianqian Li
Journal:  Int Ophthalmol       Date:  2020-07-31       Impact factor: 2.031

3.  Combined phacoemulsification and goniosynechialysis with or without endoscopic cyclophotocoagulation in the treatment of PACG with cataract.

Authors:  Wan-Shu Zhou; Wen-Xiang Lin; Yun-Yun Geng; Tao Wang
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

4.  Goniosynechialysis combined with cataract extraction for iridoschisis: A case report.

Authors:  Zhipeng You; Yan Qin; Guodong Li; Ke Shi
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

5.  Surgical outcomes of phacoemulsification/goniosynechialysis with and without endocyclophotocoagulation in patients with chronic angle closure glaucoma.

Authors:  Ketaki Panse; Crystal Le; Margaret Hubbell; Ramesh S Ayyala
Journal:  Indian J Ophthalmol       Date:  2019-03       Impact factor: 1.848

6.  Explantation of BrightOcular cosmetic iris implant and goniosynechialysis: A case report.

Authors:  David J Mathew; Avner Belkin; Matthew B Schlenker
Journal:  Indian J Ophthalmol       Date:  2019-08       Impact factor: 1.848

7.  Early versus Delayed Phacoemulsification and Intraocular Lens Implantation for Acute Primary Angle-Closure.

Authors:  Yun-Hsuan Lin; Cheng-Hsiu Wu; Shih-Ming Huang; Chen Hsieh; Henry Shen-Lih Chen; Wan-Chen Ku; Ming-Hui Sun; Wei-Wen Su
Journal:  J Ophthalmol       Date:  2020-03-24       Impact factor: 1.909

8.  Efficacy and safety of phacoemulsification plus goniosynechialysis and trabectome in patients with primary angle-closure glaucoma.

Authors:  Yu Wang; Zhi-Qiao Liang; Yu Zhang; Lauren Hennein; Ying Han; Hui-Juan Wu
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

9.  Phacoemulsification with Intraocular Implantation of Lens, Endocyclophotocoagulation, and Endoscopic-Goniosynechialysis (PIECES): A Combined Technique for the Management of Extensive Synechial Primary Angle Closure Glaucoma.

Authors:  Pouya Alaghband; Ian As Rodrigues; Saurabh Goyal
Journal:  J Curr Glaucoma Pract       Date:  2018-03-01

10.  Evaluation of Two Different Anterior Vitrectomies for Fluid Misdirection Syndrome Secondary to Cataract Surgery Combined with Goniosynechialysis.

Authors:  Zhenbin Qian; Yau Kei Chan; Liqing Wei; Bin Zheng; Li Nie; Weihua Pan
Journal:  J Ophthalmol       Date:  2020-03-23       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.